Quick Overview: Moderator: Mark McClellan, MD, PhD – FDA Commissioner, 2002-2004 Debaters: (Yes) – Mathai Mammen, MD, PhD – CEO, ... Moderator: Andy Plump, MD, PhD – President, Research and Development at Takeda Pharmaceutical Debaters: (Yes) – Scott ... Panelists: Mark Taisey – Senior Vice President, Global Regulatory Affairs & Strategy, Amgen Janet Woodcock, MD – Former FDA ...

2025 Cersi Summit Debate 1 - Detailed Overview & Context

Moderator: Mark McClellan, MD, PhD – FDA Commissioner, 2002-2004 Debaters: (Yes) – Mathai Mammen, MD, PhD – CEO, ... Moderator: Andy Plump, MD, PhD – President, Research and Development at Takeda Pharmaceutical Debaters: (Yes) – Scott ... Panelists: Mark Taisey – Senior Vice President, Global Regulatory Affairs & Strategy, Amgen Janet Woodcock, MD – Former FDA ... FDA Commissioner Robert Califf's Year in Review at the 6th Annual UCSF-Stanford Moderators: Kathy Giacomini, PhD, BSPharm– Co-PI, UCSF-Stanford Ensuring a level playing field in high-tech has never been easy for regulators and antitrust enforcers. AI is going to make it harder.

Moderators: Andy Plump, MD, PhD – President, Research and Development at Takeda Pharmaceutical Janet Woodcock, MD ... Moderator: Kuldev Singh, MD, MPH – Professor of Ophthalmology at Stanford University Debaters: (Yes) – Aaron Kesselheim, MD ... Kathy Giacomini, PhD, BSPharm – Co-PI, UCSF-Stanford Moderators: Laura Esserman, MD, MBA – Professor of Surgery and Radiology at UCSF Michelle A. Williams, ScD – Professor of ... Please join the CSIS China Power Project, Freeman Chair in China Studies, and the Trustee Chair in Chinese Business and ... Archival video of the Global Observatory's

Remarks by: Kathy Giacomini, PhD, BSPharm – Co-PI, UCSF-Stanford Please join the CSIS Bipartisan Alliance for Health Security on Wednesday, September 10, from 4 to 6 pm for the book launch of ... Stanford professors Alvin Roth and Debra Satz discuss kidney markets. Deep disagreement pervades our democracy, from ...

Photo Gallery

2025 CERSI Summit - Debate 1: Should FDA be More Transparent in Reporting Sponsor-Level Decisions?
2025 CERSI Summit - Debate 2: Should there be a Firewall Between FDA Regulatory Policy & Drug Costs?
2025 CERSI Summit - Panel 1: Generative AI in Regulatory Science
2025 CERSI Summit - FDA Commissioner's Year in Review
2025 CERSI Summit - Panel 3: FDA Center Directors Forum
SIEPR Summit 2025 | Battles between Little Tech, Big Tech
2025 CERSI Summit - Panel 4: FDA Chiefs Chat
2024 CERSI Summit - Debate 2: Should Advisory Committees Always Vote?
2025 CERSI Summit - Closing Remarks
2025 CERSI Summit - Panel 2: Women's Health
China's Power: Up for Debate 2025 AM Session
2025 Solutions Summit: Reimagining Education, AI, and Civic Life
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored